Jilin Zixin Pharmaceutical Industrial Co.,Ltd researches, develops, produces, and sells Chinese medicines and gene sequencers in China. It provides ginseng drugs, prescription drugs, and OTC drugs. The company offers its products in the form of pills, tablets, hard capsules, oral liquids, granules, oral solutions, mixtures, soft capsules, and lozenges. Jilin Zixin Pharmaceutical Industrial Co.,Ltd was founded in 1998 and is based in Changchun, China.
Research context
Jilin Zixin Pharmaceutical Industrial Co.,Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Jilin Zixin Pharmaceutical Industrial Co.,Ltd is currently in a long term downtrend where the price is trading 14.7% below its 200 day moving average.
From a valuation standpoint, the stock is 32.9% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 12.8.
Jilin Zixin Pharmaceutical Industrial Co.,Ltd's total revenue sank by 45.6% to $79M since the same quarter in the previous year.
Its net income has dropped by 1935.0% to $-63M since the same quarter in the previous year.
Finally, its free cash flow fell by 90.9% to $8M since the same quarter in the previous year.
Based on the above factors, Jilin Zixin Pharmaceutical Industrial Co.,Ltd gets an overall score of 0/5.